DIHYDRONAPHTHO[2,3-b]BENZOFURAN DERIVATIVE

The present invention provides a dihydronaphtho[2,3-b]benzofuran derivative represented by formula (1) that can be applied to the prevention and treatment of NTRK fusion-gene-positive cancers (such as non-small-cell lung cancer), a pharmacologically acceptable salt thereof, solvates of these, and a...

Full description

Saved in:
Bibliographic Details
Main Authors TANAKA, Hiroshi, AOKI, Masahide, TOMIZAWA, Masaki, NISHII, Hiroki
Format Patent
LanguageEnglish
French
Japanese
Published 04.05.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a dihydronaphtho[2,3-b]benzofuran derivative represented by formula (1) that can be applied to the prevention and treatment of NTRK fusion-gene-positive cancers (such as non-small-cell lung cancer), a pharmacologically acceptable salt thereof, solvates of these, and a pharmaceutical composition containing these as an active ingredient. La présente invention concerne un dérivé de dihydronaphtho [2,3-b]benzofurane représenté par la formule (1) et pouvant être utilisé dans la prévention et le traitement des cancers du gène de fusion NTRK (tel que le cancer du poumon non à petites cellules), un sel pharmacologiquement acceptable de celui-ci, des solvates de ceux-ci, et une composition pharmaceutique contenant ceux-ci en tant que principe actif. 本発明は、NTRK融合遺伝子陽性のがん(非小細胞肺がんなど)の予防および治療へ適用できる、式(1)で表されるジヒドロナフト[2,3-b]ベンゾフラン誘導体化合物、その薬学的に許容され得る塩、またはそれらの溶媒和物、およびそれらを有効成分として含有する医薬組成物である。
Bibliography:Application Number: WO2016JP81988